Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Goodwill (2020 - 2026)

Bioventus filings provide 6 years of Goodwill readings, the most recent being $7.5 million for Q4 2025.

  • On a quarterly basis, Goodwill changed 0.0% to $7.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.5 million, a 0.0% change, with the full-year FY2025 number at $7.5 million, changed 0.0% from a year prior.
  • Goodwill hit $7.5 million in Q4 2025 for Bioventus, roughly flat from $7.5 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $148.0 million in Q2 2022 to a low of $7.5 million in Q4 2022.
  • Median Goodwill over the past 5 years was $7.5 million (2022), compared with a mean of $35.5 million.
  • Biggest five-year swings in Goodwill: skyrocketed 196.43% in 2021 and later tumbled 94.96% in 2023.
  • Bioventus' Goodwill stood at $147.6 million in 2021, then crashed by 94.95% to $7.5 million in 2022, then changed by 0.0% to $7.5 million in 2023, then changed by 0.0% to $7.5 million in 2024, then changed by 0.0% to $7.5 million in 2025.
  • The last three reported values for Goodwill were $7.5 million (Q4 2025), $7.5 million (Q3 2025), and $7.5 million (Q2 2025) per Business Quant data.